Sudarshan Chemical Industries · NSE: SUDARSCHEM · BSE: 506655

Q3 FY26 results · Oct–Dec 2025

Sudarshan Chemical Industries reported revenue from operations of ₹2,103.00 crore (up 215.6% from Q3 FY25) and net loss of ₹116.00 crore for Q3 FY26 (Oct–Dec 2025), on a consolidated basis.

Consolidated · ₹ crore
Item	Q3 FY26	Q3 FY25	YoY	Q2 FY26	QoQ
Revenue from operations	2,103.00	666.43	+215.6%	2,387.40	−11.9%
Other income	14.20	4.49	+216.2%	28.80	−50.7%
Total income	2,117.20	670.92	+215.6%	2,416.20	−12.4%
Profit before share of associates & JVs and tax	(130.30)	4.69	Turned loss	20.20	Turned loss
Share of profit/(loss) of associates & JVs	7.50	0.00		9.30
Net profit for the period	(116.00)	0.51	Turned loss	19.30	Turned loss
Attributable to shareholders of the company	(115.30)	0.51	Turned loss	11.70	Turned loss
EPS, basic (₹)	(14.70)	0.10	not comparable	1.50	Turned loss
Net margin (%)	-5.5	0.1		0.8

This company reports a share of profit/(loss) from associates and joint ventures. BSE’s filing format records that share after tax, so it is shown on its own line. The company’s own statement may add it before its “profit before tax” line.

Standalone · ₹ crore
Item	Q3 FY26	Q3 FY25	YoY	Q2 FY26	QoQ
Revenue from operations	550.30	574.78	−4.3%	582.50	−5.5%
Other income	20.70	4.43	+367.1%	22.40	−7.6%
Total income	571.00	579.22	−1.4%	604.90	−5.6%
Profit before tax	20.00	23.07	−13.3%	74.90	−73.3%
Net profit for the period	22.50	16.24	+38.6%	74.10	−69.6%
EPS, basic (₹)	2.90	2.30	not comparable	9.50	−69.5%
Net margin (%)	4.1	2.8		12.7

Consolidated

Filed with BSE: 12 Feb 2026, 20:06 IST
Board meeting: 12 Feb 2026
Period: 01 Oct 2025 to 31 Dec 2025
Review status: Unaudited
Source: XBRL filing on BSE

Standalone

Filed with BSE: 12 Feb 2026, 20:06 IST
Board meeting: 12 Feb 2026
Period: 01 Oct 2025 to 31 Dec 2025
Review status: Unaudited
Source: XBRL filing on BSE